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Abstract
Non-invasive prenatal testing (NIPT) demonstrated a small chance for a false negative
result. Since the “fetal” DNA in maternal blood originates from the cytotrophoblast of chori-
onic villi (CV), some false negative results will have a biological origin. Based on our experi-
ence with cytogenetic studies of CV, we tried to estimate this risk. 5967 CV samples of
pregnancies at high risk for common aneuplodies were cytogenetically investigated in our
centre between January 2000 and December 2011. All cases of fetal trisomy 13, 18 and 21
were retrospectively studied for the presence of a normal karyotype or mosaicism < 30% in
short-term cultured (STC-) villi. 404 cases of trisomies 13, 18 and 21 were found amongst
5967 samples (6,8%). Of these 404 cases, 14 (3,7%) had a normal or low mosaic karyotype
in STC-villi and therefore would potentially be missed with NIPT. It involved 2% (5/242) of all
trisomy 21 cases and 7.3% (9/123) of all trisomy 18 cases. In 1:426 (14/5967) NIPT sam-
ples of patients at high risk for common aneuploidies, a trisomy 18 or 21 will potentially be
missed due to the biological phenomenon of absence of the chromosome aberration in the
cytotrophoblast.
Introduction
The validation of non-invasive prenatal testing (NIPT) for fetal trisomy detection revealed that
there is a small chance of a false positive and false negative result [1]. Although technical limi-
tations may explain these false results, both also have a biological basis. The fact that cell free
‘fetal’ DNA in the maternal plasma fraction originates from the cytotrophoblast of chorionic
villi (CV) explains at least a part of the discrepancies between NIPT results and the actual fetal
karyotype [2–4].
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In order to understand the biological origin of false positive and false negative NIPT results,
it is important to understand the cytogenetics of chorionic villi. CV can be processed for cyto-
genetic studies in two ways: the direct or semi-direct technique [5, 6], also called short-term
cultured villi (STC-villi) and the long-term preparation method (long-term cultured villi
(LTC-villi)) [7]. The origin of the cells that are investigated in the cytogenetic preparations are
essentially different in both techniques: cells in STC-villi are derived from the cytotrophoblast,
the outer cell layer of CV, and those of LTC-villi are predominantly from the inner cell layer,
the mesenchymal core (Fig 1). The gold standard for cytogenetic analysis of CV is investigation
of both STC (cytotrophoblast)- and LTC (mesenchymal core)-villi [8]. With NIPT, only DNA
from the cytotrophoblast is investigated and therefore the results will be comparable to those
from STC-villi.
As early as in the Eighties chromosome analyses of STC- and LTC-villi, have revealed that
the chromosomal constitution of the cytotrophoblast may differ from that of the mesenchymal
core and that of the fetus [9]. This is the consequence of the different embryonic origins of the
Fig 1. Early embryonic development from zygote to blastocyst. The cytotrophoblast which is studied in short-term cultured villi (STC-villi) and with NIPT
is derived from the trophoblast of the blastocyst, whereas the mesenchymal core, investigated in long-term cultured villi (LTC-villi) originates from the extra-
embryonic mesoderm (EEM). Both EEM and fetus are derived from the inner cell mass (ICM) of the blastocyst.
doi:10.1371/journal.pone.0146794.g001
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three compartments mentioned. The cytotrophoblast is derived from the trophoblast of the
blastocyst, whereas the mesenchymal core of the CV as well as the fetus itself are derived from
the inner cell mass (ICM) (Fig 1). More particularly, the mesenchymal core originates from the
hypoblast of the ICM and the fetus itself from the epiblast [10, 11]. Postzygotic mitotic division
errors in chromosomally normal as well as abnormal conceptuses will lead to chromosomal
mosaicism which is found in about 1 to 2% of CV [12]. Due to the uneven distribution of
abnormal cells over the different compartments, the karyotypes of cytotrophoblast, mesenchy-
mal core and fetus may be different [13]. In most of these mosaic cases the chromosomally
abnormal cell line is confined to the cytotrophoblast and/or the mesenchymal core of CV,
while the fetus itself has a normal karyotype [8, 12]. This phenomenon is called confined pla-
cental mosaicism (CPM) [14] and it accounts for 72% of all cases of mosaicism detected in CV
[15]. Of the three possible types of CPM, the one with a (mosaic) chromosome aberration con-
fined to the cytotrophoblast and not present in mesenchymal core or fetus, namely CPM type
1, is the most prevalent. CPM type 1 will cause a false positive NIPT result if the percentage of
abnormal cells in the cytotrophoblast is sufficiently high [16]. The same is true for the less
prevalent CPM type 3 with chromosomally abnormal cells restricted to both cell layers of the
CV and absent in the fetus itself.
On the other hand, chromosomal mosaicism may also lead to false negative NIPT results.
Two types of mosaicism are associated with a normal karyotype in the cytotrophoblast while
the fetus itself has a chromosome aberration. Firstly, generalised mosaicism confined direct
normality (GMDD)[12], characterized by the presence of a chromosome aberration in the
fetus and mesenchymal core of the placenta, with the cytotrophoblast being chromosomally
normal. Secondly, although extremely rare, confined fetal mosaicism (CFM) with a normal
karyotype in STC-and LTC-villi and with ultimately abnormal cytogenetic results in the fetus
[12, 17]. Both types of mosaicism will show normal NIPT results due to a normal karyotype in
the cytotrophoblast, the fetus having an abnormal karyotype though. The types of generalized
mosaicism with absolute or relative concordance (GMAC or GMRC, respectively) may poten-
tially also go undetected with NIPT if the percentage of abnormal cells in STC-villi is below a
certain threshold [18].
In clinical practice, it is now generally accepted that if NIPT reveals a trisomy 13, 18 or 21,
follow-up investigations by an invasive procedure, preferentially amniocentesis, are necessary
to confirm the results, because NIPT is not fully diagnostic [19–21]. This will reveal false posi-
tive results and by doing so, an unnecessary termination of pregnancy may be prevented. How-
ever, it is as important to realize that if the NIPT result is normal, there is a possibility that this
result is falsely negative.
Little information is available with regard to false negative NIPT results, apart from a few
reported cases [1]. Studies on false negative NIPT results would require thorough follow-up
investigations of all tested pregnancies, including cytogenetic investigations of those resulting
in a miscarriage or intrauterine fetal demise. In order to study the risk for a biological false neg-
ative NIPT result involving the chromosomes 13, 18 and 21, we retrospectively investigated all
CV cases of fetal trisomy 13, 18 and 21 that were found in our centre during a 12-year period
(January 2000-December 2011). We determined the proportion of cases with normal or low-
level mosaicism in STC-villi that potentially would lead to false negative NIPT results.
Materials and Methods
All cases of fetal trisomy 13, 18 and 21 among 5967 CV samples that were cytogenetically
investigated in our centre during a 12-year period (January 2000-December 2011) were retro-
spectively studied for the presence of a normal karyotype or low-level mosaicism< 30% in
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STC-villi. The samples were obtained under continuous ultrasound guidance by transabdom-
inal aspiration. The threshold of 30% was chosen based on previously published papers [16,
22]. The main indications for CV sampling in these trisomic cases were fetal ultrasound abnor-
malities, increased nuchal translucency, advanced maternal age> 36 years, and/or abnormal
first trimester screening results (risk>1:200). Patients undergoing prenatal diagnosis at our
medical university are informed that we may investigate (publish) their medical data as long as
all data remain anonymised. Each patient had the opportunity to object to this. No objections
were made.
This study overlaps with the study of van den Berg et al. (2006) which describes the results
in 2389 CV samples investigated during the time period November 2000 and July 2005.
Despite our standard protocol during the study period in which we routinely performed
STC- as well as LTC-villi, in most trisomy 21 cases only STC villi were analysed since this chro-
mosome aberration can be considered a “certain abnormality” when encountered in STC-villi,
irrespective of the indication[8]. Similarly, in most cases of a fulblown trisomy 13 and 18, the
karyotyping was restricted to that of STC-villi if fetal ultrasound anomalies, detected at the
time of CV sampling matched the chromosome aberration.[8]. In all other cases (normal or
mosaic results in STC-villi or 100% trisomy 13 or 18 in STC-villi without ultrasound abnor-
malities), LTC-villi were investigated as well. GTG banding was routinely used in all cases. At
least 8 metaphases in STC-villi (range 8–21) and 10 in LTC-villi (range 10–25) were studied.
Additionally, in most mosaic cases FISH on interphase nuclei was performed in order to
exclude the presence of low-level mosaicism in karyotypically normal STC-villi, or in order to
further study the level of mosaicism in mosaic STC and/or LTC-cases.
Results
On 5967 CV samples, a total of 404 (6.7%) fetal trisomies 13, 18 and 21 were found. All these
cases were considered to be true cases of fetal trisomy due to:
1. the presence of 100% trisomy in LTC-villi
2. the presence of 100% trisomy 13 or 18 in STC-villi in association with fetal ultrasound
abnormalities that matched the abnormal karyotype
3. the presence of 100% trisomy 21 in STC-villi, irrespective of the indication as described by
van den Berg et al. [8, 23].
Of these 404 cases, 14 (3.7%) had a normal (N = 9) or low-mosaic (<30%) (N = 5) karyo-
type in STC-villi and therefore would potentially be missed if NIPT was performed in these
cases (Table 1). This means that in 14/5967 high risk pregnancies a trisomy will potentially be
missed with NIPT based on biological grounds.
Trisomy 21 (Table 2): 242 cases of fetal trisomy 21 were encountered among 5967 CV sam-
ples of which 5 (2.0%) showed karyotypically normal STC results (N = 3) or low-level mosai-
cism (N = 2). In two out of three cases with karyotypically normal STC, additional FISH on
200 nuclei revealed low-level mosaicism of 23% and 8%. LTC-villi in these cases showed a non-
mosaic trisomy 21 karyotype. The indications for sampling were an increased nuchal translu-
cency (N = 3), ultrasound anomalies (N = 1) and abnormal first trimester screening result
without an enlarged nuchal translucency (N = 1). Nine cases of high-level mosaicism (> 30%)
in STC-villi associated with 100% trisomy 21 in LTC-villi were found. Those cases were
assumed to be detectable with NIPT.
Trisomy 18 (Table 3): a total of 123 cases of fetal trisomy 18 were found in 5967 CV samples
of which 9 (7.3%) showed normal (N = 6) or low mosaic abnormal (N = 3) STC results and
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would likely be missed with NIPT. Interphase FISH (100–200 nuclei) excluded mosaicism in
the six normal cases. The indication for CV sampling was the detection of fetal ultrasound
abnormalities in all cases. One case of high level mosaicism (87%) in STC-villi was found and
assumed to be detectable with NIPT.
Trisomy 13: a total of 39 cases of trisomy 13 were found and in all cases a 100% (n = 38) or
high mosaic (86%) karyotype was found in STC-villi. Therefore, none of the trisomy 13 cases
would potentially be missed with NIPT. The indication for CV sampling was the detection of
fetal ultrasound abnormalities in all cases.
Discussion
Cell free ‘fetal’ DNA in maternal blood originates from the cytotrophoblast [2] and is not
always concordant with true fetal DNA. This will explain at least some of the false positive and
false negative NIPT results that are currently published. After the introduction of chorionic vil-
lus (CV) sampling as an alternative to amniocentesis in the early Eighties, for a short time,
cytogenetic studies in chorionic villi were performed solely on preparations from the cytotro-
phoblast in many laboratories around the world [5]. However, soon after its introduction we
learned that the karyotype of this cell layer, which is derived from the trophoblast of the blasto-
cyst [10] is not always representative for that of the fetus. This is due to chromosomal mosai-
cism with uneven distribution of normal and abnormal cells over the different compartments
(trophoblast, extraembryonic mesoderm and fetus) of a conceptus [12, 24]. This phenomenon
led the publication of many papers on false positive and negative results in CV and to a
change of protocol advocating the use of two culture methods: STC-villi investigating the
Table 1. Number of fetal trisomy 13, 18 and 21 cases amongst 5967 CV samples with karyotypically normal results or low-level mosaicism <30% in
STC-villi.
Chromosome
aberration
Total number of trisomic
cases
Number with normal
STC
Number with mosaic
STC<30%
Total number of normal or
mosaic < 30% STC (%)
Trisomy 21 242 3 2 5 (2,0%)
Trisomy 18 123 6 3 9 (7.3%)
Trisomy 13 39 0 0 0
Total 404 9 5 14 (3,5%)
doi:10.1371/journal.pone.0146794.t001
Table 2. Details of trisomy 21 cases with normal or low-mosaic (<30%) results in STC-villi in our cohort of 5967 CV samples.
Indication Karyotype STC-villi
(% +21)
FISH STC: % +21
(number of cells)
Karyotype
LTC-villi
FISH LTC: % +21
(number of cells)
Conﬁrmatory studies
1 Hygroma colli/
AMA37
46,XY[10] (0%) 23% interphase nuclei
(N = 200)
47,XY,+21[11] —— —
2 NT 6mm/
AMA36
46,XX[8] (0%) 0% metaphases (N = 38) 47,XX,+21[16] 100% metaphases
(N = 44)
Skin biopsy: 100% interphase
nuclei (N = 50)
3 ftCT 1:10 46,XY[11] (0%) 8% interphase nuclei
(N = 205)
47,XY,+21[21] 100% interphase nuclei
(N = 100)
—
4 NT 6.9mm/ ftCT
1:2
47,XY,+21[4]/46,XY
[11] (27%)
— 47,XY,+21[19] — —
5 NT 5.5mm/ ftCT
1:5
47,XX,+21[3]/46,XX
[17] (15%)
— 47,XX,+21[16] — —
AMA: advanced maternal age ( 36yrs); NT: nuchal translucency; ftCT: abnormal ﬁrst trimester combined screening test results; STC-villi: short-term
cultured villi; LTC-villi: long-term cultured villi
doi:10.1371/journal.pone.0146794.t002
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cytotrophoblast and LTC-villi investigating the mesenchymal core of CV. It was shown that
only the analysis of both methods will lead to a high degree of accuracy [9]. With the introduc-
tion of NIPT “l’histore se repète”. Moreover, due to the origin of the cell free ‘fetal’ DNA and
the possibility of chromosomal mosaicism, a 100% sensitivity and specificity for NIPT can and
will never be reached.
Knowing that with NIPT we are investigating the cytotrophoblast of CV, risk figures for
false positive and false negative NIPT results should be derivable from CV figures. Therefore,
we performed a retrospective analysis of our CV data of 5967 patients at high risk for the com-
mona aneuploidies, mainly AMA> 36 years, ftCT (abnormal first trimester combined test
results> 1:200), increased NT and other ultrasound abnormalities. Cases of chromosomal
mosaicism with normal results or low level mosaicism< 30% in STC-villi and a full blown tri-
somy 13, 18, 21 in LTC-villi and/or fetus were collected in order to determine the potential
incidence of false negative NIPT results. The present study shows that in 0.2% (14/5967) (95%
CI 0.13%-0.39%) of patients at high risk for common aneuploidies, a false negative NIPT result
for trisomy 13, 18 and 21 can be expected. This figure seems to be higher than the figures on
false negative STC-villi reported in the literature (see Table 4). This is partially explained by the
inclusion of low mosaic cases in our presented data, so that for a sound comparison these
mosaic cases preferably should be excluded. Doing this, the false negative rate in our series in
fact would still be 0.15% (9/5967) (95% CI 0.07%-0.29%)(Table 1), which is in agreement with
our previously published data (van den Berg et al. 2006), but would still be higher than the few
Table 3. Details of trisomy 18 cases with normal or low-mosaic (<30%) results in STC-villi in our cohort of 5967 CV samples.
Indication Karyotype STC-villi (%
+18)
FISH STC % +18
(N100 nuclei)
Karyotype
LTC-villi
FISH LTC %
+18 (N100
nuclei)
Conﬁrmatory studies
1 US: omphalocele,
hygroma colli, hydrops
foetalis; hydrothorax
46,XX[8] (0%) 0% 47,XX,+18[14]/
46,XX[2]
~100%* Skin: 100% metaphases
(N = 61),and ~100%*
interphase nuclei (N = 100)
2 US: IUGR 46,XX[10] (0%) 0% 47,XX,+18[16] ~100%* Skin: ~100%* interphase
nuclei (N = 100)
3 US: hydrops foetalis, cor
vitium, abdominal wall
defect
46,XX[9] (0%) 0% 47,XX,+18[25] — —
4 US: NT 8 mm, IUGR 47,XY,+18[3]/46,XY[18]
(14%)
0% 47,XY,+18[9]/
46,XY[1]
~100%* —
5 US: omphalocele, NT 6
mm, ftCT 1:2
46,XX[10] (0%) 0% 47,XX,+18[9] ~100%* —
6 US: hydrops foetalis, IUD 46,XY[7] (0%) 0% 47,XY,+18[7]/
46,XX[7] (MCC)
~100%* (in Y-
positive
nuclei)
—
7 US: hydrops foetalis,
ascites, NT 7 mm
46,XY[9] (0%) 0% 47,XY,+18[8]/
47,XY,+2[10]
38% +18 (and
32% +2)
AF: ~100%* interphase
nuclei (N = 165)
8 US: encephalocele, IUGR 48,XY,+mar,+18[1]/47,
XY,+18[2]/47,XY,+mar
[11]/46,XY[5] (16%)
FISH for mar
identiﬁcation: mar = der
(18)(L1.84+, WCP18-)
47,XY,+18[11] ~100% * Skin: ~100%*
9 US: hygroma colli 47,XX,+18[2]/46,XX[18]
(10%)
0% 47,XX,+18[16] — —
US: ultrasound abnormalities; IUGR: intrauterine growth restriction; IUD: intrauterine death; NT: nuchal translucency; ftCT: abnormal ﬁrst trimester
screening results; AF: uncultured amniotic ﬂuid cells; MCC: maternal cell contamination; STC-villi: short-term cultured villi; LTC-villi: long-term cultured villi
* The % of nuclei with 3 signals with probe L1.84 (18 centromere probe) varied between 70 and 100%, ﬁtting a non-mosaic trisomy 18 according to our
protocol.
doi:10.1371/journal.pone.0146794.t003
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published figures (see Table 4). The most likely explanation is the difference in indications for
sampling shown by a lower incidence of trisomies 13, 18 and 21 in the paper of Grati et al. [25]
(3% versus 7% (404/5967) in our patient group) (Table 4). This is also confirmed by the paper
of Toutain et al. [26, 27] who found an incidence of GMDD of 1/386 (0.26%) in a small series
of CV sampled for increased nuchal translucency or other ultrasound abnormalities. So,
depending on whether there is a high or low risk for aneuploidy, the estimated chance for a
false negative NIPT diagnosis will vary between 0.02% and 0.26% (Table 4). However, a few
things should be taken into account. Firstly, these figures are probably overestimated due to
the well-known placental variation in cases of mosaicism. Therefore, it cannot be excluded that
a CV biopsy in the first trimester may miss cytogenetically abnormal cotylydones that probably
will lead to abnormal NIPT results assuming deposition of the whole placental cytotrophoblast
into the maternal circulation. However, in our opinion we consider the risk to be minimal
since all samples were obtained under continuous ultrasound guidance by transabdominal
instead of transcervical aspiration. Secondly, based on current experience [16, 22] a mosaic of
less than 30% is expected to be missed with NIPT. However, this for sure will highly depend on
fetal fraction with a 100% trisomy potentially missed if fetal fraction is too low and a 30%
mosaic detected if fetal fraction is high.
Especially the risk for a false negative trisomy 18 is obvious, with in the present study 7.3%
of all fetal cases with a trisomy 18 potentially being missed if NIPT was performed. The prefer-
ential involvement of trisomy 18 in GMDD can also be recognised in the recent paper of Grati
et al. [25] (6 out of 382 cases (1,6%)), but also in the former CV literature (ACC CVS database
2005). In fact, Porreco et al. [28] who conducted a prospective multicenter observational study
comparing NIPT with the results of invasive testing in 3430 cases at high risk of common aneu-
ploidies, found 3 out of 38 cases of trisomy 18 (7.9%) to have a false-negative NIPT result.
It is reasonable to think that the actual prevalence of false negative NIPT results may even
be higher than the figures mentioned. False negative results due to technical problems such as a
low fetal DNA fraction for instance as a consequence of high BMI [29, 30, 31] or of some fetal
aneuploidies [32] are a well know problem and should be added to these figures. On the other
hand, the risk of a false negative NIPT result due to confined fetal mosaicism (CFM) can prob-
ably be ignored. This type of mosaicism is extremely rare, probably less than 0.003%, although
absolute figures are not available due to incomplete follow-up investigations [17].
So far little information is available on the true prevalence of false negative NIPT results. An
emerging number of case reports on this topic are published though [1]. Therefore, based on
the estimated risk of missing 3.5% (14/404) of fetal trisomies 13, 18 and 21 with NIPT, as
shown in this paper, we would like to recommend follow-up cytogenetic testing in all cases
with normal NIPT results if fetal anomalies are detected by ultrasound, if a miscarriage or
Table 4. False negative cytogenetic results in STC-villi involving trisomy 13, 18 and 21: literature review.
Reference Total number of
CV
Number of false negative STC
(%)
Number of trisomies 13, 18, 21 on total number of samples
(%)
Grati et al. 2014 52,673 15 (0.03%) 1599 (3.0%)
Battaglia et al. 2014 7112 3 (0.04%) Not given
Smith et al. 1999 7934 7 (0.09%) Not given
Pittalis et al. 1994 4860 1 (0.02%) 87 (1.8%)
Van den Berg et al.
2006
2389 4 (0.17%) Not given
Toutain et al. 2010 386 1 (0.26%) 70 (18.1%)
Present study 5967 9 (0.15%) 404 (6.7%)
doi:10.1371/journal.pone.0146794.t004
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intrauterine death occurs and if a syndromally abnormal child is born. In such cases we would
like to encourage cytogenetic testing of both fetus or child and placenta. This will ultimately
lead to a better knowledge on the true prevalence of false negative NIPT results.
In conclusion, a retrospective analysis of ~6000 CV samples of patients at high risk of aneu-
ploidy revealed that in 1:426 (14/5967) pregnancies a fetal trisomy 13, 18, 21 may potentially
be missed with NIPT due to absence of the chromosome aberration in the cytotrophoblast.
Moreover, irrespective of the indication we could calculate that 2% (5/242) and 7.3% (9/123) of
trisomies 21 and 18, respectively, may likely not be detected with NIPT due to a chromosom-
ally normal or low mosaic cytotrophoblast. Due to the relatively small number of cases, for tri-
somy 13 this figure remains unclear. Since most trisomic fetuses, especially those with trisomy
13 or 18, will show anomalies that are detectable by ultrasound, part of these false negatives
will be discovered later on during pregnancy or will end in an intrauterine death. It is impor-
tant that patients opting for NIPT are informed about both the technical and biological limita-
tions of the non-invasive prenatal procedure so that an informed choice can be made between
non-invasive targeted testing and invasive sampling with cytogenetic testing of CV or amnio-
cytes [33]. In the meanwhile, thorough follow-up investigations in cases of normal NIPT
results will ultimately lead to the real figures for NIPT sensitivity.
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